To validate the results from our drug library screens, we tested camptothecin and its derivatives SN-38 and 10-HCPT using dose–response curves on the MLL-rearranged and BCP-ALL cell lines used in the original drug library screens, and additionally included the T-ALL cell line Jurkat. Here, KMT2A is linked to acute lymphoblastic leukemia.